Upregulation of salivary α2 macroglobulin in patients with type 2 diabetes mellitus
“Upregulation of salivary α2 macroglobulin in patients with type 2 diabetes mellitus”, vol. 14, pp. 2268-2274, 2015.
, We investigated the expression of salivary α2-macroglobulin (α2-MG) in patients with type 2 diabetes mellitus (T2DM) to investigate its value for predicting damage to the salivary glands. A total of 116 patients with T2DM and 60 patients with impaired fasting glucose (IFG) were included in this study. Sixty health volunteers were enrolled as a control group. Unstimulated saliva was collected at 8 a.m. prior to breakfast. Expression of α2-MG was determined using an enzyme-linked immunosorbent assay.